Like many cardiologists, Shoa Clarke, MD, PhD, has noticed that some of his patients, despite extreme modification to their diets, can’t move the needle on their cholesterol levels, while other patients show dramatic swings.
“We have people who come into clinic and say, ‘I changed my diet and it made no difference in my cholesterol.’ Or they say, ‘I changed my diet and it had a huge effect on my cholesterol,’” said Clarke, an assistant professor of medicine and of pediatrics.
Those observations motivated him and his colleagues to research the impact of genetics on cholesterol levels and saturated fat intake. Clarke is the senior author of the Stanford Medicine-led study, publishing Nov. 18 in JACC: Advances.
The researchers looked at data on nearly 21,000 women whose genes had been sequenced and who reported their diets. First, they reproduced the known association between higher saturated fat intake and higher low-density lipoprotein (LDL) cholesterol — the “bad” kind that can clog arteries. They then found that this association differed according to genetics. For women with genetic propensity for high cholesterol, the effects of saturated fat were exaggerated, but for women without the predisposition, the effects were diminished.
“Sometimes people think, ‘Oh, if I’m genetically prone to something, then it doesn’t really matter what my diet is or what the environment is like; it’s genetically predetermined.’ But what we’re saying here is the opposite,” Clarke said. “The people who had this genetic predisposition for higher LDL were actually the ones with the most sensitivity to diet, where diet has the best chance of helping them — or hurting them, if the diet is not good.”
Heart attacks and strokes
The study also looked at participants’ risks of experiencing cardiovascular disease-associated events such as heart attacks and strokes. Despite progress in prevention and treatment, cardiovascular disease remains the No. 1 cause of death for both men and women in the United States and around the world. The results again found that the top 25% of participants who had a genetic propensity for high LDL levels and who consumed more saturated fat than others were significantly likelier to suffer such events. For the remaining 75% of participants, higher saturated fat intake did not markedly increase the risk of cardiovascular events.
“We found the same thing — that the association between saturated fat intake and risk for having cardiovascular events was amplified for those people at the upper end of the genetic spectrum,” Clarke said. “This variation in response to saturated fat may be one of the reasons there is so much controversy and disagreement over how much is OK in a diet.”
The new study builds off work by Clarke and Stanford Medicine colleagues including Themistocles Assimes, MD, PhD, a professor of cardiovascular medicine and coauthor of the new paper. In a 2021 Nature study, Stanford Medicine researchers and colleagues developed a highly effective polygenic risk score, a tool for predicting the genetic risk of having high cholesterol levels. The data pool included more than 1.6 million individuals from diverse ancestries.
Clarke and colleagues applied their polygenic risk score to the new study’s more than 21,000 women, who came from the Women’s Health Initiative, a long-term national health study launched in 1991. At the start of the study, the median age of the participants was 65 years; about half self-identified as white, a third as Black and about 15% as Hispanic. Study participants reported their dietary consumption for three months, covering frequency and portion sizes for 122 foods and beverages, and they had their fasting cholesterol levels checked.
Ketogenic diets
While major health institutions such as the American Heart Association and the World Health Organization advise limiting red meat consumption because of its high saturated fat levels, some popular diets, such as ketogenic diets, contrarily embrace low-carb, high-protein and high-fat foods. Clarke noted, however, even for people on the low end of risk in the study, eating more saturated fat did not confer any kind of protective effect, though their risk of cardiovascular events remained low.
“The effects of saturated fat may not be the same for everyone, but there isn’t any evidence of a cardiovascular benefit to eating more saturated fat,” Clarke said. “The harms might vary from small to large depending on who you are.”
He added that healthy cholesterol levels reported by some people on high-fat ketogenic diets fit into the concept of underlying genetics having tremendous influence on how high or low someone’s bad cholesterol gets.
“There’s extensive heterogeneity,” Clarke said. “It’s really hard to extrapolate to everyone.”
To understand what happens at the individual level after diet change is the obvious next step in this line of research, Clarke said, and he and his colleagues have already started down that road. At NUTRITION 2026, the annual meeting of the American Society for Nutrition held in July, Alexa Barad, PhD, a postdoctoral scholar in Clarke’s lab, presented preliminary findings that support the new JACC: Advances study. “Our initial findings show that individuals with high polygenic scores were at increased risk for developing high cholesterol after adopting a low-carb diet,” Clarke said.
Translation to the clinic
In addition to further investigating individual-level results, Clarke and others plan to continue developing the polygenic scores approach and mustering more clinical evidence. Already, some medical practices have started to factor in polygenic scores, and Stanford Medicine has piloted its inclusion in cancer and cardiovascular clinical care settings.
“We don’t yet have evidence that polygenic risk scores should be used to guide diet recommendations,” Clarke said. “But that certainly is a future area of study, and from what our results in this new study suggest, could indeed be a fruitful one.”
Clarke envisions one day having the ability to tailor recommendations for lifestyle interventions, such as particular types of diets or modes of exercise according to various factors including a patient’s genetics. “That’s at least the hope of this idea of ‘precision prevention’ that we’d like to advance,” he said.
As a preventive cardiologist, Clarke has noted the strides the field has made over the last 50 years, with cholesterol-reducing medications, tobacco control and more, helping reduce age-adjusted cardiovascular mortality by more than half. Progress has slowed, though, and with an aging world population and spreading of high-fat Westernized diets, the need for better prevention is critical.
“On one hand, we’ve seen that a focus on prevention in cardiology is effective, and it can really make a big difference,” Clarke said. “On the other hand, it’s clear that the job’s not done, and there’s a lot more to do.”
Researchers from Penn State College of Medicine; Northwestern University; University of California, San Diego; University of Massachusetts Amherst; Drexel University; UCLA; and Brigham and Women’s Hospital, Harvard Medical School contributed to the research.
The study was funded by the American Heart Association Postdoctoral Fellowship and the National Institutes of Health (contracts 75N92021D00001, 75N92021D00002, 75N92021D00003, 75N92021D00004, 75N92021D00005 and 1R01HL188164-01).
# # #
About Stanford Medicine
Stanford Medicine is an integrated academic health system comprising the Stanford School of Medicine and adult and pediatric health care delivery systems. Together, they harness the full potential of biomedicine through collaborative research, education and clinical care for patients. For more information, please visit med.stanford.edu.
Journal
Journal of the American College of Cardiology
Method of Research
Experimental study
Subject of Research
People
Article Title
Association between saturated fat intake and low-density lipoprotein cholesterol across the genetic spectrum
Article Publication Date
18-Nov-2026